ResearcherFirst Affiliated Hospital of Anhui Medical UniversityNo recent work listed

Aman Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4821-0886; OpenAlex author ID A5101844126. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

The prognostic evaluation of CA19-9, D-dimer and TNFAIP3/A20 in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1097/md.0000000000024651 ↗
A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fonc.2020.00583 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lixiang Zhang · 1 shared paper, 2020 · strength 0.19
- Paper A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Ad… DOI 10.3389/fonc.2020.00583 ↗
Peng Xu · 1 shared paper, 2021 · strength 0.16
- Paper The prognostic evaluation of CA19-9, D-dimer and TNFAIP3/A20 in patients with pancreatic ductal adenocarcinoma. DOI 10.1097/md.0000000000024651 ↗
Jianjun Qian · 1 shared paper, 2021 · strength 0.16
- Paper The prognostic evaluation of CA19-9, D-dimer and TNFAIP3/A20 in patients with pancreatic ductal adenocarcinoma. DOI 10.1097/md.0000000000024651 ↗
Jie J. Yao · 1 shared paper, 2021 · strength 0.16
- Paper The prognostic evaluation of CA19-9, D-dimer and TNFAIP3/A20 in patients with pancreatic ductal adenocarcinoma. DOI 10.1097/md.0000000000024651 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.